Guest guest Posted February 24, 2010 Report Share Posted February 24, 2010 Have we any doubt that large-N studies of vaccinated vs unvaccinated (re: Prevnar 13) will be insisted upon by the FDA, HHS, and ACIP? After all, what's more important, Pfizer revenues or vaccination safety? - - - - Vaccine Approved for Child Infections By DUFF WILSON February 24, 2010 http://www.nytimes.com/2010/02/25/business/25vaccine.html The Food and Drug Administration on Wednesday approved Prevnar 13, an expanded version of a vaccine to protect children against more forms of bacterial infections that can cause meningitis, pneumonia and other diseases. Health officials say such infections cause a million deaths a year in developing countries and dozens of deaths in the United States, along with ear infections in millions of infants. Prevnar 13, from the drug giant Pfizer, adds protection against six types of bacteria to a current product, Prevnar 7, increasing its coverage to more than 90 percent of pneumococcal disease rather than the current product’s 80 percent coverage. Prevnar 7 had worldwide sales approaching $3 billion, making it one of the Pfizer’s best-selling drugs, and Credit Suisse analysts predict Prevnar 13 will exceed $5 billion in sales by 2014. Pfizer is counting on it to become the company’s top revenue generator after its flagship drug, the cholesterol fighter Lipitor, loses patent protection next year... http://www.nytimes.com/2010/02/25/business/25vaccine.html .. Sheri Nakken, R.N., MA, Hahnemannian Homeopath Vaccination Information & Choice Network, Washington State, USA Vaccines - http://vaccinationdangers.wordpress.com/ Homeopathy http://homeopathycures.wordpress.com Vaccine Dangers, Childhood Disease Classes & Homeopathy Online/email courses - next classes start February 24 & 25 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.